Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 49,324 | 73,694 | 58,555 | 31,106 | 715 |
| Cost of Goods | 42,715 | 23,101 | 31,518 | 31,368 | 7,261 |
| Gross Profit | 6,609 | 50,593 | 27,037 | -262 | -6,546 |
| Operating Expenses | 128,545 | 137,270 | 116,621 | 102,020 | 111,437 |
| Operating Income | -121,221 | -86,576 | -89,066 | -101,914 | -117,722 |
| Other Income | 3,220 | 9,575 | 4,005 | 3,355 | 3,338 |
| Pre-tax Income | -118,001 | -77,001 | -85,061 | -98,559 | -114,384 |
| Income Tax | -1,838 | 1,558 | -1,520 | -1,458 | -1,408 |
| Net Income Continuous | -116,163 | -78,559 | -83,541 | -97,101 | -112,976 |
| Net Income | $-116,163 | $-78,559 | $-83,541 | $-97,101 | $-112,976 |
| EPS Basic Total Ops | -0.36 | -0.24 | -0.28 | -0.34 | -0.42 |
| EPS Basic Continuous Ops | -0.36 | -0.24 | -0.28 | -0.34 | -0.42 |
| EPS Diluted Total Ops | -0.36 | -0.24 | -0.28 | -0.34 | -0.42 |
| EPS Diluted Continuous Ops | -0.36 | -0.24 | -0.28 | -0.34 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.36 | -0.26 | -0.28 | -0.34 | N/A |
| EBITDA(a) | $-110,286 | $-72,184 | $-81,585 | $-93,549 | $-110,150 |